 Today I have the pleasure of speaking with Thomas Smeak from Hema Stemix. How are you today Thomas? I'm very well Tracy. Nice to see you again. We're really looking forward to this update ever since you trademarked your fountain of youth and we have a deal I think a partnership deal with Dr. James Shapiro that to me sounds significant. What are the highlights of this please? Yes it's actually a blockbuster in my view. Here's the world famous Dr. James Shapiro who is famous for creating the Edmonton protocol essentially treating type 1 diabetes and he's looked at ACP and he believes ACP will help him treat type 1 diabetes more fruitfully and so we're delighted to be working with him. As per our conversation we had just before we start this interview I would love it if you could share with our audience an update on what was it ACP, HSP, HCP and NCP please. Yes so NCP is the nerve cell precursor and there's going to be a lot of news flow over the next 12 months on the studies that we're doing on NCP. HCP is essentially a heart cell precursor so following a heart attack we have a stem cell that comes from the patient's own blood that promises to treat the heart following a heart attack and we're going to be working on bringing that to market as well. Okay and of course you also just finished a financing can you tell us a little bit more about what the use of proceeds will be with this financing? Yes the private placement is oversubscribed. We'll be using the proceeds to fund the NCP work as well as close out the phase two results and I believe announce the phase three study. I thought this was very interesting. You announced just recently that you have trademarked your fountain of youth. What's that? That's very exciting. I'm certain there's a lot of people online typing in fountain of youth. Yes your fountain of youth is really descriptive of our business and our business plan. You know this is a concept that is as old as mankind and we've all been searching for the fountain of youth and here it is it's in our stem cells and so our business plan is to leverage the individual's stem cells to create a quality of life and maintain a quality of life that they enjoy you know as young, virulent individuals and so that's really I think in our lifetime Tracy you, me, our loved ones we will be probably on an annual basis using our stem cells to maintain our quality of life. Well Thomas thank you so much for this update and indeed your look into the future I hope is coming sooner than later. Thank you. Very welcome Tracy thank you.